SACK1B and ovarian cancer: MTT assay showed FAM83B overexpression significantly inhibited ovarian cancer cell proliferation and cisplatin resistance, while FAM83B knockdown significantly increased ovarian cancer cell proliferation and cisplatin resistance (Fig. 3b).